Alembic Pharmaceuticals Ltd
Brajesh Shukla is an experienced professional in the pharmaceutical industry, with a background in Medicinal and Pharmaceutical Chemistry. Brajesh has held various positions in the Intellectual Property Cell of different pharmaceutical companies, where BRAJESH has been involved in a wide range of IP related activities, including FTO strategies for formulations development, ANDA filing, and patentability evaluation. Brajesh has provided technical support to legal teams during litigation/patent oppositions and regulatory affairs. In addition, Brajesh has a Bachelor of Laws in Legal Studies and a PG diploma in Pharma Regulatory Affairs, showcasing their diverse skill set in the pharmaceutical and legal fields.
This person is not in the org chart
This person is not in any offices
Alembic Pharmaceuticals Ltd
8 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.